Crucial research and thousands of jobs are at risk because the Australian biotech industry has been largely locked out of the federal government’s COVID-19 support efforts, according to AusBiotech....
The federal government’s “ill-informed” reforms to the research and development tax incentive will damage Australia’s burgeoning life sciences sector at a time when it is at the forefront of...
The Life Sciences industry in Australia will be hit disproportionately hard by proposed changes to the R&D Tax Incentive, putting smaller companies at risk and threatening the sector’s ability...
Potential changes to the R&D tax incentive would “devastate” the booming biotechnology industry in Australia, a new report has found. The Biotechnology Industry Position Survey 2017 found that the...